Mangalam Drugs & Organics Q4 Results

  • BSE: 532637
  • NSE: MANGALAM
  • ISIN: INE584F01014
  • Sector: Biotechnology & Drugs
BSE
105.85-1.05 (-0.98%)
Volume2.28 K
Updated: Mon 25 Nov, 2024 | 15:28:14
NSE
106.021.00 (0.95%)
Volume15.90 K
Updated: Mon 25 Nov, 2024 | 15:43:33
Today: 103.00
108.75
52-Wk: 85.16
144.65

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Mangalam Drugs & Organics Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 102.2363.33-%91.11-%
    Selling/ General/ Admin Expenses Total 11.119.43-%6.29-%
    Depreciation/ Amortization 3.862.88-%2.75-%
    Other Operating Expenses Total 20.789.15-%7.25-%
    Total Operating Expense 94.4059.74-%93.61-%
    Operating Income 7.823.59-%-2.51-%
    Net Income Before Taxes 3.930.50-%-5.65-%
    Net Income 3.530.43-%-4.39-%
    Diluted Normalized EPS 2.230.27-%-2.78-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts